The global Hospital-acquired Disease Testing Market market size is expected to reach USD 3,968.2 million by 2030, registering a CAGR of 20.0% from 2023 to 2030, according to a new report by Coherent Market Insights Inc.
When a patient develops a localized or systemic condition as a result of an adverse reaction to contagious toxin agents during medical care, the condition is considered to be hospital acquired, also known as nosocomial infection or healthcare-associated infection. Extended time in the hospital, the development of antibiotic resistance, permanent disabilities, and an increased risk of death are all consequences of hospital-acquired infections. Hospital-acquired infections can be caused by a wide variety of microorganisms, including viruses, fungi, and bacteria.
Bloodstream infections, surgical site infections, pneumonia caused by mechanical ventilation, and UTIs caused by catheters are all examples of hospital-acquired diseases. Hospital-acquired infections can be avoided, identified, and tested for with the help of microarrays, polymerase chain reactions (PCRs), and solid-phase hybridizations. Patients who use urinary catheters are at increased risk for urinary tract infections because the urethra is so close to the anus, allowing bacteria to easily pass from the GI tract into the urinary system.
Request Sample Report + All Related Graphs & Charts:
https://www.coherentmarketinsights.com/insight/request-sample/992
We have an updated report [Version – 2023] available.
(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)
Our Sample Report May Includes:
• 2030 Updated Report Introduction, Overview, and In-depth industry analysis.
• 100+ Pages Research Report (Inclusion of Updated Research).
• Provide Chapter-wise guidance on Requests.
• 2023 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
• Includes Updated List of tables & figures.
• Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis.
Competitive Landscape:
The given section on the global Hospital-acquired Disease Testing Market Market will include an extensive examination of the various players in this industry, their respective company overviews, an analysis of existing product portfolios, financials, etc. We even include a supply-chain analysis, a PEST analysis, market probability scenarios, Porter’s Five Forces analysis, and other related frameworks that are meant to aid in the expansion of your reputed organization. The specific application of these given findings allows all our clients to apply essential yet accurate data when formulating the most-suitable business strategies with the aim of improving their business’ footprint in this global industry.
Top Key Players:
★ Luminex Corporation
★ Diatherix Laboratories
★ Life Technologies
★ Cantel Medical Corporation
★ Meridian Biosciences Inc
★ Nordion Inc
★ Qiagen GmbH
★ F.Hoffmann-La Roche Ltd.
★ Biomérieux
★ Cepheid.
Over the next few years, rising rates of hospital-acquired infections are expected to fuel market expansion
In the predicted period, the hospital-acquired disease testing market is anticipated to grow due to the increasing prevalence of infections like CLABSI (central line associated bloodstream infection ), CRBSI (catheter-related bloodstream infection), and others. For example, every year there are roughly 30,000 cases of CLABSI reported in the United States, as reported at the National Healthcare Safety Network Bloodstream Infection Surveillance in March of 2018. Prolonged hospitalization due to CLABSI has been linked to increased patient costs and mortality.
Furthermore, approximately 250,000 cases of blood stream infections are reported annually in the United States, in accordance to statistics released by the International Society for Infectious Diseases in March 2018. About 80,000 of these are ICU-acquired CRBSI (catheter-related bloodstream infections).
There will be a rise in the hospital-acquired disease testing market as more and better testing equipment and kits become available
Companies are putting a lot of effort into creating cutting-edge testing kits in an effort to improve the speed and accuracy with which hospitals can diagnose hospital-acquired diseases. For example, in December 2019, the U.S. Food and Drug Administration (FDA) approved cobas vivoDx MRSA, a diagnostic test developed by F.Hoffmann-La Roche Ltd. to detect Methicillin-resistant Staphylococcus aureus (MRSA). The introduction of cobas vivoDx MRSA into clinical practise is intended to facilitate the reduction of MRSA infections and their prevention in healthcare facilities.
However, the availability of sophisticated hospital-acquired disease tests in developed countries is reducing the prevalence of nosocomial infections, which is expected to slow the market in the near future.
We Offer Customized Report, Click:
https://www.coherentmarketinsights.com/insight/request-customization/992
Purchasing the Hospital-acquired Disease Testing Market Market:
➣ Outlook for the worldwide Hospital-acquired Disease Testing Market market in both developed and emerging markets, both now and in the future.
➣ Both the market segment with the largest projected share and the market segment with the highest CAGR throughout the projection period.
➣ Countries and regions anticipated to experience the fastest development throughout the projected period.
➣ The most recent innovations, market shares, and business tactics used by the key market participants.
➣ Study examines emerging market trends as well as the likelihood that various trends will impact expansion.
➣ Analysis also discusses the factors, challenges, and opportunities that will have a significant impact on the global Hospital-acquired Disease Testing Market industry.
➣ Research includes a detailed analysis of market statistics as well as historical and current growth conditions in order to provide futuristic growth estimates.
Purchase This Complete Business Report:
https://www.coherentmarketinsights.com/insight/buy-now/992
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Hospital-acquired Disease Testing Market Market Size Analysis from 2023 to 2030
11.6 COVID-19 Outbreak: Hospital-acquired Disease Testing Market Industry Impact
Chapter 2 Global Hospital-acquired Disease Testing Market Competition by Types, Applications, and Top Regions and Countries
2.1 Global Hospital-acquired Disease Testing Market (Volume and Value) by Type
2.3 Global Hospital-acquired Disease Testing Market (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Hospital-acquired Disease Testing Market Sales, Consumption, Export, Import by Regions (2017-2023)
Chapter 5 North America Hospital-acquired Disease Testing Market Market Analysis
Chapter 6 East Asia Hospital-acquired Disease Testing Market Market Analysis
Chapter 7 Europe Hospital-acquired Disease Testing Market Market Analysis
Chapter 8 South Asia Hospital-acquired Disease Testing Market Market Analysis
Chapter 9 Southeast Asia Hospital-acquired Disease Testing Market Market Analysis
Chapter 10 Middle East Hospital-acquired Disease Testing Market Market Analysis
Chapter 11 Africa Hospital-acquired Disease Testing Market Market Analysis
Chapter 12 Oceania Hospital-acquired Disease Testing Market Market Analysis
Chapter 13 South America Hospital-acquired Disease Testing Market Market Analysis
Chapter 14 Company Profiles and Key Figures in Hospital-acquired Disease Testing Market Business
Chapter 15 Global Hospital-acquired Disease Testing Market Market Forecast (2023-2030)
Chapter 16 Conclusions
Explore More Related Insights:
Enteroviruses Testing Kit Market
Infectious disease diagnostics market
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame
CA 94010, United States
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
JAPAN: +81-50-5539-1737
INDIA: +91-848-285-0837